BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32681048)

  • 1. Prediction-based highly sensitive CRISPR off-target validation using target-specific DNA enrichment.
    Kang SH; Lee WJ; An JH; Lee JH; Kim YH; Kim H; Oh Y; Park YH; Jin YB; Jun BH; Hur JK; Kim SU; Lee SH
    Nat Commun; 2020 Jul; 11(1):3596. PubMed ID: 32681048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering guide RNA to reduce the off-target effects of CRISPR.
    Wu J; Yin H
    J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric DNA-RNA Guide RNA Designs.
    Lu S; Zhang Y; Yin H
    Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
    Zhang B; Zhou J; Li M; Wei Y; Wang J; Wang Y; Shi P; Li X; Huang Z; Tang H; Song Z
    Anal Bioanal Chem; 2021 Apr; 413(9):2447-2456. PubMed ID: 33661348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OffScan: a universal and fast CRISPR off-target sites detection tool.
    Cui Y; Liao X; Peng S; Tang T; Huang C; Yang C
    BMC Genomics; 2020 Mar; 21(Suppl 1):872. PubMed ID: 32138651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide target specificity of CRISPR RNA-guided adenine base editors.
    Kim D; Kim DE; Lee G; Cho SI; Kim JS
    Nat Biotechnol; 2019 Apr; 37(4):430-435. PubMed ID: 30833658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing.
    Li J; Hong S; Chen W; Zuo E; Yang H
    J Genet Genomics; 2019 Nov; 46(11):513-521. PubMed ID: 31911131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq.
    Kim D; Kang BC; Kim JS
    Nat Protoc; 2021 Feb; 16(2):1170-1192. PubMed ID: 33462439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
    Kim D; Luk K; Wolfe SA; Kim JS
    Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEG-seq: an ion torrent-adapted NGS workflow for in cellulo mapping of CRISPR specificity.
    Tang PZ; Ding B; Peng L; Mozhayskiy V; Potter J; Chesnut JD
    Biotechniques; 2018 Nov; 65(5):259-267. PubMed ID: 30114933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.